It is well established that the vast majority of human tumour-associated antigens (such as carcinoembryonic antigen, Her2, and glypican-3) are not truly or absolutely tumour-specific and, whilst amplified on malignant cells, are often detectable at very low levels on normal cells in a wide variety of organ systems. The gene discussed is GPC3; the disease is neoplasm.